High Tower Advisors, LLC Clovis Oncology, Inc. Call Options Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $1,163 - $3,267	-100 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $151,416 - $224,640	-3,600 Reduced 97.3%	100 $0
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $185,444 - $250,564	3,700 New	3,700 $2,000
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $69,228 - $101,496	-1,200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $13,434 - $16,962	200 Added 20.0%	1,200 $5,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,000	1,000 $11,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.